| Overview |
| bs-0130R-Cy5.5 |
| SARS S-protein polyclonal, Cy5.5 Conjugated |
| WB |
| Virus |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from SARS S-protein |
| 401-500/1255 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 1489668 |
| P59594 |
| Spike glycoprotein, S glycoprotein, E2, Peplomer protein |
| Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV). Human coronaviruses (HCoVs) were previously only associated with mild diseases. The SARS-CoV genome contains five major open reading frames (ORFs) that encode the replicase polyprotein; the spike (S), envelope (E), and membrane (M) glycoproteins; and the nucleocapsid protein (N). |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz